For more than a decade, the Food and Drug Administration (FDA) has made diversity in clinical trials a focus, including by issuing guidance, convening public-private workshops, and completing data analyses in an effort to...more
2/6/2025
/ Clinical Trials ,
Department of Health and Human Services (HHS) ,
Diversity ,
Diversity and Inclusion Standards (D&I) ,
Draft Guidance ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Healthcare ,
Life Sciences ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Trump Administration